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Subunit III (BSIII) of the bovine ternary complex of procarboxypeptidase A-S6 (PCPA-S6), a defective serine endopep- 
tidase-like protein, actively synthesized by the pancreas of some ruminant species, is highly homologous to human prote- 
ase E (HPE). Both proteins possess the same atypical disulfide bridge in position 98899b. They are structurally related 
to porcine elastase 1 and human elastase 2 (about 56% identity). However, in contrast to those two enzymes which have 
an overall positive net charge, BSIII and HPE are negatively charged. Three-dimensional models of BSIII and HPE have 
been constructed from the crystallographic structure of porcine pancreatic elastase 1. The inhibitor-binding site for TFAI 
in these three proteins seems to be very similar; the atypical disulfide bridge does not seem to be involved in this binding 
site. The specific structural features of BSIII and HPE strongly support the assumption that BSIII is a truncated protease 
E and that both proteins belong to a separate serine endopeptidase family. 
Serine protease; Inactive protease; Protease E; (Pancreas). 
1. INTRODUCTION 
Several families of zymogens of serine endopep- 
tidases have been identified in pancreatic exocrine 
secretion. This family distinction is mainly based 
on the substrate specificity of the various pro- 
teases. 
Protease E, the activation product of zymogen 
E, has been identified in human [l], porcine [2] 
and bovine [3] pancreas. Since this protease 
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catalyses esterolysis of the typical elastase model 
substrate, N-acetyl tri-L-alanine methyl ester, it 
has often been identified as an elastase [4]. Yet, in 
contrast to elastase 1 [5] and 2 [6], protease E has 
a low pl and fails to hydrolyze insoluble elastin 
[1,4,71. 
Porcine protease E is the only member of the 
family for which the specificity has been delineated 
[7]. It is complementary to that of chymotrypsin: 
porcine protease E shows a pronounced specificity 
for cleaving after the carbonyl group of hydrox- 
yamino acids (serine, threonine), valine and 
alanine, the latter being most favoured. The 
human enzyme has been reported to have a similar 
specificity [ 11. 
Besides the protease E described by Kobayashi et 
al. [3], bovine pancreas produces large amounts of 
a non-covalent ernary complex (PCPA-S6) [8,9]. 
This association is formed of two zymogens, the 
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(- ) Identical residues between (i) PEl and BSIII, (ii) BSIII and HPE; (.) missing residue (deletion); (I I) residues of the active site, 
within 5 A from the inhibitor TFAI; (m) when residues are different, interaction involves main chain; (s) when residues differ, 
interaction involves side chain; (*) charge modification between BSIII and HPE 
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procarboxypeptidase A itself and a chymotryp- 
sinogen of the C type, and a defective serine 
endopeptidase-like protein called subunit III 
[l&12]. This type of complex has only been found 
in some ruminant species [13]. Subunit III 
possesses a weakly functional active site unable to 
hydrolyze the specific substrates of the pancreatic 
serine endopeptidases [ 12,141. All invariant 
residues essential to the activity of pancreatic 
serine endopeptidases are present in subunit III, 
except for the two strongly hydrophobic N- 
terminal residues characteristic of this class of en- 
zymes [ 111. As supported by three-dimensional 
modelling [12], the absence of these residues 
prevents the formation of the salt bridge (16-194) 
(chymotrypsinogen A numbering system) known 
to stabilize the active conformation of serine pro- 
teases. The very low catalytic efficiency of the pro- 
tein would result from a defective binding site [ 121. 
Another salient structural feature of BSIII is the 
presence of an atypical disulfide bridge in position 
98-99b. 
Sequence comparison clearly shows that BSIII is 
structurally close to an elastase (56% identity with 
PEl and human elastase 2). 
The recent elucidation of the human protease E 
sequence [ 151 allows one to observe a very high 
homology between BSIII and HPE. Here, we 
discuss the consequences of this finding and report 
more precise investigations of the active site of 
both proteins by computer modelling. 
2. EXPERIMENTAL 
2. I. Protein modeiling 
The models of BSIII and HPE have been derived from the 
crystallographic structure of porcine pancreatic elastase I [16] 
after the respective sequences were aligned (table 1). Construc- 
tion of the three-dimensional molecular models was according 
to [12] through computer graphics techniques: sequence diting, 
modifications, insertions or deletions of amino acids and 
regularization of the structure were performed with the 
FRODO program [17] on a Silicon Graphics IRIS 3020 color 
display workstation. The resulting models have been refined 
through energy-minimization methods with the program EREF 
[18] on a DEC Microvax II. 
2.2. Charge analysis 
A set of programs which perform calculations of the centers 
of mass of negatively and positively charged residues and 
calculate their distance has been written. These programs have 
been interfaced with FRODO. 
3. RESULTS 
3.1. Sequence comparison 
Venot et al. [ 1 l] reported a detailed comparison 
of the sequences of BSIII and PEl and Shen et al. 
[ 151 carefully studied the sequence homologies be- 
tween HPE and rat and porcine elastases 1 and 2. 
Both proteins were shown to contain all the 
residues which contribute to catalysis as well as the 
four disulfide bridges characteristic of rat [ 191 and 
porcine [20] elastase 1. However, some discrepan- 
cies were noted and the sequence identity between 
BSIII or HPE and the above-mentioned elastases 
was no more than 56-57% (table 1). As reported 
by Venot et al. [l 11, BSIII possesses an additional 
atypical disulfide bridge (98-99b) which has been 
found in no other pancreatic serine endopep- 
tidases. The presence of two cysteine residues at 
the same position in the mRNA-based sequence of 
HPE [ 151 is in strong support of the same disulfide 
bridge existing in this protease. Moreover, com- 
parison of the sequences of HPE and BSIII reveals 
a striking homology between those two proteins, 
since out of 242 residues only 34 are different (in- 
cluding the two missing N-terminal residues in 
BSIII), leading to a score of 86% identity. 
3.2. Three-dimensional model& and active-site 
mapping 
The modelling of BSIII [12] and HPE to PEl in- 
dicates a close conformational fit between the ter- 
tiary structures of the three proteins, as expected 
from their high degree of homology. A more 
precise investigation of the topology of the binding 
site of BSIII and HPE has also been performed by 
inserting an elastase inhibitor (TFAI) into the 
models. 
The coordinates for the crystallographic struc- 
ture of the PEl-TFAI inhibitor complex [21] were 
obtained from the Protein Data Bank. Subse- 
quently, the coordinates of TFAI were inserted in- 
to the models of BSIII and HPE. For the three 
proteins, 17 residues were found at less than 5 A 
from any atom of the TFAI, defining the inhibitor- 
binding site. This could be done without further 
remodelling, since TFAI-protein distances were 
kept within a normal Van der Waals contact range. 
Inspection of table 1 shows that 3 residues of this 
site differ between PEl and BSIII, 2 between BSIII 
and HPE and 4 between PEl and HPE. Never- 
93 
Volume 232, number 1 FEBS LETTERS May 1988 
Table 2 
Charge analysis for porcine elastase 1, subunit III and human 
protease E 
PEl BSIII HPE 
K+R (+l) 15 14 15 
H (+0.5) 6 I 6 
Sum + 18 17.5 18 
D+E (-1) 11 25 24 
Net charge +I -7.5 -6 
d(CM+-CM-) (A) 3.1 5.0 1.5 
d(CM+-CM-), distance between centers of mass of positive 
and negative charges 
theless, these changes either imply the main chain 
of the residue or are quite conservative (S-T or Q- 
N). Therefore, the inhibitor-binding site of these 3 
proteins should be equivalent. 
3.3. Charge analysis 
HPE as well as BSIII exhibits a negative net 
charge (table 2). In contrast, PEl and human 
elastase 2 have an overall positive charge. Out of 
the 34 residues ubstituted from BSIII to HPE, 13 
correspond to a charge alteration leading to a 
slightly different localization of charges. This is 
also evident when considering the distances be- 
tween the centers of mass of respectively positive 
and negative charges (table 2). 
4. DISCUSSION 
The striking structural similarities between BSIII 
and HPE clearly indicate that the two proteins are 
very closely related and strongly support the 
assumption that subunit III is a truncated protease 
E.. 
The lack of activity of BSIII has already been at- 
tributed to the absence of residues 16 and 17 
which, by preventing the formation of the ion pair 
(N-terminal)-(Asp-194), should lead to an altered 
active site. The existence of an active protein very 
close to BSIII but bearing residues 16 and 17 con- 
firms our hypothesis. Moreover, the presence of 
the atypical disulfide bridge cannot be responsible 
for the inactivity of BSIII, as previously suggested 
[12], since it is expected to exist in active protease 
E. 
The identification of BSIII as a protease E is fur- 
94 
ther supported by reassociation experiments how- 
ing that BSIII and porcine zymogen E bind to the 
same (or part of the same) site on bovine and por- 
cine procarboxypeptidases A [13]. The binding 
between BSIII and bovine procarboxypeptidase A 
mainly involves electrostatic interactions [22]. 
Nevertheless, due to the large number of charged 
residues substitutions between BSIII and HPE, it 
does not seem that the charge recognition pattern 
is very specific. 
The classification of pancreatic serine endopep- 
tidases is not easy, as illustrated by the case of 
elastases. A first distinction should be made be- 
tween true elastases able to digest insoluble elastin 
(including 2 families [23]: a pancreatic elastase 
family represented by porcine and rat elastase 1 
and a chymotrypsin-like lastolytic protease family 
represented by porcine and human elastase 2) and 
non-elastolytic proteases resembling elastase which 
hydrolyse only elastase synthetic substrates. 
Although hydrolysing the synthetic substrate of 
elastase and bearing some of its structural 
characteristics, protease E is a non-elastolytic en- 
zyme. The specific structural features of BSIII and 
HPE (including the S-S bridge pattern) strongly 
support the assumption that both proteins belong 
to a separate pancreatic serine endopeptidase fami- 
ly, the protease E family. 
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